This weekend we celebrate the Science and Technology Festival at Ciutadella’s Park, Barcelona. Researchers of the Cognition and Brain Plasticity group at IDIBELL have prepared several activities to teach the little ones as often what we see and perceive does not correspond with reality. With these experiments, aimed at people over six years, the researchers […]
Find out how the brain tricks us in the Science Festival Read More »
Researcher Antoni Castells of the IDIBAPS explained the present and the future of screening techniques for colon cancer, the most common cancer and second leading cause of death in Spain. It was on May 31 at a conference framed in IDIBELL seminar series. “The techniques we use today, despite having limitations, are effective and cost-effective”
Antoni Castells: ”We need to find new tools for colon cancer screening” Read More »
Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) and Vall d’Hebron Research Institute (VHIR) have shown that administration of genetically modified mesenchymal stem cells regenerates lung tissue and stops the inflammatory process in mice with acute lung injury. Study results were published in the American Journal of Respiratory Cell and Molecular Biology. Acute lung injury
Genetically modified stem cells are effective against acute respiratory diseases Read More »
Researchers observed that genes that protect from cancer as the vitamin A receptor alter its activity in colon cancer cells by the presence of spherical structures formed by DNA (in this case expression regulatory regions of genes) and proteins called histones. “We have observed,” said the researcher Manel Esteller, “that epigenetic drugs, capable of demethylating
The IDIBELL is preparing the strategic plan, which will guide its actions over the next few years. This is a fundamental instrument in order to be able to articulate the actions the IDIBELL will develop over the coming years and which replaces the plan realized in 2007, valid till the end of 2012. This document
Researchers of the IDIBELL have shown that a drug used to control Type II diabetes can help repair the spinal cords of mice suffering from the inherited disease adrenoleukodystrophy which, untreated, leads eventually to a paralysis, a vegetative state and death. This is an important step along the road to the development of a therapy
A diabetes drug, a promising treatment for neurodegenerative disease Read More »
Bring together different researchers to promote a multidisciplinary debate focused on music with the aim to exchange opinions and to provide an information as complete as possible about its effects on the evolution of our species, as well as in the attitudes, emotions, and social behavior, has been the intention of the cycle “The music
Researchers of the Epigenetics and Cancer Biology Program at IDIBELL, led by researcher Maribel Parra, have identified a transcriptional repressor, histone deacetylase HDAC7, involved in the identity of B cells, the cells responsible to create antibodies in our immune system. The results of the study, published in PLoS Genetics, show that HDAC7 is expressed specifically
Identified a key protein in maintaining the identity of B lymphocytes Read More »
The Cardiovascular Research Laboratory of the IDIBELL led by the cardiologist of the Bellvitge University Hospital José Luis Ferreiro has conducted a study on the effect of antiplatelet drugs given to high risk patients suffering from acute myocardial infaction (heart attack) in the context of the Infarction Code. The study concludes that when patients arrive
